483
Dr. Arun Ravindran, MBBS MSc., PhDDr. Arun Ravindran, MBBS MSc., PhD – FDA 483, Jan 11, 2019
Record Details
The FDA inspected Dr. Arun Ravindran, a clinical investigator in Toronto, regarding a study on Esketamine for treatment-resistant depression. The inspection revealed that the investigation was not conducted in accordance with the investigational plan. Specifically, two subjects were enrolled and treated with investigational product despite meeting exclusion criteria related to prohibited concomitant therapies.
View Company Profile
ID · 08469234-4ed9-4c30-ad74-c6300b707bc3
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.